Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea

Radhakrishnan Venkatasamy, Clive Page, Domenico Spina
European Respiratory Journal 2015 46: PA3960; DOI: 10.1183/13993003.congress-2015.PA3960
Radhakrishnan Venkatasamy
Sackler Institute of Pulmonary Pharmacology, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clive Page
Sackler Institute of Pulmonary Pharmacology, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Domenico Spina
Sackler Institute of Pulmonary Pharmacology, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 46 no. suppl 59
DOI 
https://doi.org/10.1183/13993003.congress-2015.PA3960

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online October 30, 2015.

Copyright & Usage 
Copyright ©ERS 2015

Author Information

  1. Radhakrishnan Venkatasamy,
  2. Clive Page and
  3. Domenico Spina
  1. Sackler Institute of Pulmonary Pharmacology, King's College London, London, United Kingdom

Article usage

Article usage: November 2015 to April 2023

AbstractFullPdf
Nov 20152600
Dec 20151200
Jan 20161700
Feb 20161300
Mar 2016904
Apr 20161608
May 2016600
Jun 20161101
Jul 2016300
Aug 2016800
Sep 201615023
Oct 2016700
Nov 20161600
Dec 20161200
Jan 20171000
Feb 20171200
Mar 20171000
Apr 20171200
May 20171100
Jun 2017500
Jul 2017800
Aug 2017900
Sep 2017400
Oct 2017600
Nov 20171200
Dec 20171200
Jan 20181400
Feb 2018200
Mar 20181400
Apr 20181200
May 2018700
Jun 2018500
Jul 2018500
Aug 2018500
Sep 2018900
Oct 20181000
Nov 2018700
Dec 2018300
Jan 2019200
Feb 2019800
Mar 2019300
Apr 2019400
May 2019200
Jun 2019600
Jul 2019200
Aug 2019300
Sep 2019200
Oct 2019300
Nov 2019300
Dec 2019500
Jan 2020300
Feb 20201500
Mar 20201300
Apr 2020900
May 2020600
Jun 2020200
Jul 20201100
Aug 2020300
Sep 20202300
Oct 20201300
Nov 20201400
Dec 20201100
Jan 2021800
Feb 20211400
Mar 2021700
Apr 2021800
May 2021600
Jun 20211500
Jul 20212700
Aug 20214300
Sep 2021500
Oct 2021400
Nov 20211100
Dec 20211100
Jan 20221600
Feb 2022400
Mar 2022600
Apr 2022700
May 2022200
Jun 2022600
Jul 2022800
Aug 2022500
Sep 2022300
Oct 2022400
Nov 2022300
Dec 2022300
Jan 2023200
Feb 2023500
Mar 2023600
Apr 2023200

Altmetrics

Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
Radhakrishnan Venkatasamy, Clive Page, Domenico Spina
European Respiratory Journal Sep 2015, 46 (suppl 59) PA3960; DOI: 10.1183/13993003.congress-2015.PA3960

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The dual PDE3/PDE4 phosphodiesterase inhibitor RPL554 produces more complete bronchodilator responses than the beta2-agonist salbutamol and the anti-muscarinic agent ipratropium bromide, alone and in combination, in guinea-pig isolated trachea
Radhakrishnan Venkatasamy, Clive Page, Domenico Spina
European Respiratory Journal Sep 2015, 46 (suppl 59) PA3960; DOI: 10.1183/13993003.congress-2015.PA3960
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Omalizumab, airway obstruction and remodeling
  • Central role for the TRPV4-ATP-P2X3 axis in sensory nerve activation and the late asthmatic response
  • Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Show more 5.1 Airway Pharmacology and Treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society